Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)

SHE:003017 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	975.82	900.31	912.24	1,048	772.51	674.27
Other Revenue	9.64	9.64	7.22	10.43	10.7	4.06
Revenue	985.47	909.96	919.45	1,058	783.21	678.34
Revenue Growth (YoY)	12.43%	-1.03%	-13.10%	35.10%	15.46%	9.10%
Cost of Revenue	765.83	738.72	757.87	913.61	633.26	514.11
Gross Profit	219.64	171.24	161.58	144.49	149.95	164.23
Selling, General & Admin	84.27	74.93	75.1	65.94	63.34	53.11
Research & Development	34.98	28.78	39.22	34.06	27.84	22.33
Other Operating Expenses	-11.46	-7.06	-7.22	-7.69	-7.72	-8.97
Operating Expenses	107.69	97.73	105.52	94.08	83.65	67
Operating Income	111.95	73.5	56.06	50.41	66.3	97.23
Interest Expense	-4.48	-6.77	-6.14	-5.48	-2.77	-0.67
Interest & Investment Income	8.88	8.85	10.79	3.49	11.22	1.23
Currency Exchange Gain (Loss)	1.57	1.57	1.13	2.74	-0.48	-2.59
Other Non Operating Income (Expenses)	-0.38	-1.27	-0.6	-0.65	-0.1	-0.65
EBT Excluding Unusual Items	117.54	75.88	61.24	50.51	74.17	94.55
Gain (Loss) on Sale of Investments	0.62	0.36	-1.48	0.71	-0.32	1.08
Gain (Loss) on Sale of Assets	-1.54	0.09	-0.17	3.41	0.12	-0
Asset Writedown	-20.2	-7.96	-17.02	-0.19	-1.89	-1.73
Other Unusual Items	3.13	3.28	4.41	3	4.06	6.35
Pretax Income	99.55	71.64	46.99	57.45	76.14	100.26
Income Tax Expense	7.42	7.91	-3.02	-23.27	6.13	8.65
Earnings From Continuing Operations	92.13	63.74	50.01	80.73	70.01	91.61
Minority Interest in Earnings	0.39	0.01	-	-	-	-
Net Income	92.52	63.75	50.01	80.73	70.01	91.61
Net Income to Common	92.52	63.75	50.01	80.73	70.01	91.61
Net Income Growth	51.43%	27.48%	-38.05%	15.31%	-23.58%	15.23%
Shares Outstanding (Basic)	80	81	81	81	84	66
Shares Outstanding (Diluted)	81	82	81	82	84	66
Shares Change (YoY)	-0.52%	1.62%	-0.99%	-2.93%	26.42%	5.68%
EPS (Basic)	1.15	0.78	0.62	0.99	0.83	1.38
EPS (Diluted)	1.14	0.78	0.62	0.99	0.83	1.38
EPS Growth	52.22%	25.44%	-37.43%	18.79%	-39.55%	9.04%
Free Cash Flow	63.74	2.74	78.8	-12.76	-128.59	-12.33
Free Cash Flow Per Share	0.79	0.03	0.98	-0.16	-1.53	-0.19
Dividend Per Share	0.600	0.300	0.736	0.143	0.429	0.429
Dividend Growth	33.25%	-59.24%	415.05%	-66.66%	-	100.00%
Gross Margin	22.29%	18.82%	17.57%	13.66%	19.14%	24.21%
Operating Margin	11.36%	8.08%	6.10%	4.76%	8.47%	14.33%
Profit Margin	9.39%	7.00%	5.44%	7.63%	8.94%	13.51%
Free Cash Flow Margin	6.47%	0.30%	8.57%	-1.21%	-16.42%	-1.82%
EBITDA	178.38	140.95	124.86	109.8	110.54	128.53
EBITDA Margin	18.10%	15.49%	13.58%	10.38%	14.11%	18.95%
D&A For EBITDA	66.42	67.45	68.81	59.39	44.24	31.3
EBIT	111.95	73.5	56.06	50.41	66.3	97.23
EBIT Margin	11.36%	8.08%	6.10%	4.76%	8.47%	14.33%
Effective Tax Rate	7.45%	11.04%	-	-	8.05%	8.63%
Revenue as Reported	985.47	909.96	919.45	1,058	783.21	678.34
Advertising Expenses	-	0.65	0.42	0.06	4.09	3.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.